Healthcare provider profile · identity verified

Jay C Anderson, M.D.

Internal Medicine · GRAND ISLAND, NE · NPI 1649393927

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	703	153
Amlodipine Besylate	Amlodipine Besylate	545	111
Levothyroxine Sodium	Levothyroxine Sodium	445	87
Furosemide	Furosemide	366	79
Pantoprazole Sodium	Pantoprazole Sodium	286	50
Gabapentin	Gabapentin	281	50
Lisinopril	Lisinopril	279	74
Omeprazole	Omeprazole	257	60
Losartan Potassium	Losartan Potassium	256	57
Metoprolol Succinate	Metoprolol Succinate	194	51
Metformin Hcl	Metformin Hcl	185	44
Potassium Chloride	Potassium Chloride	183	43
Metoprolol Tartrate	Metoprolol Tartrate	167	35
Tamsulosin Hcl	Tamsulosin Hcl	158	40
Simvastatin	Simvastatin	155	35
Pravastatin Sodium	Pravastatin Sodium	149	34
Carvedilol	Carvedilol	135	27
Eliquis	Apixaban	129	19
Allopurinol	Allopurinol	123	31
Warfarin Sodium	Warfarin Sodium	116	25
Famotidine	Famotidine	114	23
Rosuvastatin Calcium	Rosuvastatin Calcium	103	25
Duloxetine Hcl	Duloxetine Hcl	101	17
Trazodone Hcl	Trazodone Hcl	99	16
Jardiance	Empagliflozin	96	13
Tramadol Hcl	Tramadol Hcl	89	27
Sertraline Hcl	Sertraline Hcl	88	23
Arexvy	Rsvpref3 Antigen/As01e/Pf	87	87
Clopidogrel	Clopidogrel Bisulfate	87	22
Hydrochlorothiazide	Hydrochlorothiazide	86	22
Metformin Hcl Er	Metformin Hcl	84	21
Escitalopram Oxalate	Escitalopram Oxalate	75	15
Trulicity	Dulaglutide	69	14
Fluoxetine Hcl	Fluoxetine Hcl	62	12
Fluticasone Propionate	Fluticasone Propionate	61	24
Prednisone	Prednisone	61	32
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	60	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	60	59
Spironolactone	Spironolactone	57	15
Montelukast Sodium	Montelukast Sodium	55	17
Alendronate Sodium	Alendronate Sodium	53	11
Oxycodone Hcl	Oxycodone Hcl	51	14
Ropinirole Hcl	Ropinirole Hcl	51	suppressed
Ozempic	Semaglutide	49	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	45	31
Xarelto	Rivaroxaban	44	suppressed
Baclofen	Baclofen	43	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	43	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	12
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	42	42
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	13
Meloxicam	Meloxicam	41	13
Albuterol Sulfate Hfa	Albuterol Sulfate	39	18
Alprazolam	Alprazolam	38	11
Valsartan	Valsartan	38	suppressed
Glimepiride	Glimepiride	37	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Benazepril Hcl	Benazepril Hcl	36	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	12
Pregabalin	Pregabalin	36	suppressed
Irbesartan	Irbesartan	35	suppressed
Bupropion Xl	Bupropion Hcl	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Synthroid	Levothyroxine Sodium	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Mounjaro	Tirzepatide	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	29	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Glipizide	Glipizide	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Torsemide	Torsemide	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Topiramate	Topiramate	24	suppressed
Digoxin	Digoxin	23	suppressed
Rybelsus	Semaglutide	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Ondansetron Odt	Ondansetron	22	14
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Lovastatin	Lovastatin	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Levemir Flexpen	Insulin Detemir	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	11
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Linzess	Linaclotide	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Peg-3350 And Electrolytes	Peg3350/Sod Sulf,bicarb,cl/Kcl	17	17
Aripiprazole	Aripiprazole	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Colchicine	Colchicine	16	suppressed
Fentanyl	Fentanyl	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Nystatin	Nystatin	16	suppressed
Ramipril	Ramipril	16	suppressed
Diazepam	Diazepam	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Novolog Flexpen	Insulin Aspart	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Lactulose	Lactulose	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Estradiol	Estradiol	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Metolazone	Metolazone	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Rufinamide	Rufinamide	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Cephalexin	Cephalexin	11	11
Felodipine Er	Felodipine	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error